Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Medical University of Graz
After giving informed consent, the participants will be randomized into two groups (1:1). Both groups will receive standard care while one group will additionally be assigned to a practitioner of traditional Chinese medicine (TCM) who will deliver a individual treatment according to the needs of the participant (pragmatic approach).
Outcome measures will be monitored over the course of eight weeks.
Age
18–80
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
One of the following tumor entities
* Colorectal cancer (CRC)
* Lung cancer (SCLC, NSCLC)
* Breast cancer (BC)
* Pancreas/Cholangiocellular cancer
Best supportive care (i.e., no currently ongoing tumor-specific therapy)
o Exception: palliative anti-hormonal therapy or palliative radiotherapy
Performance status: ECOG 0 to 2
Estimated life expectancy \> 4 months
You may not be if
Any serious concomitant systemic disorder
Pregnancy or breast-feeding
Impossibility to attend TCM practices in Graz
Incapacity to comply/consent
Language barrier
Brain metastases
Clareo Health | Implementing Acupuncture and Chinese Herbal Medicine Into Palliative Care
